Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
L'augmentation des coûts liés au développement de médicaments constitue une motivation importante en faveur de l'exploitation de techniques de médecine translationnelle permettant la stratification des patients. Par conséquent, la nécessité d'identifier des biomarqueurs pour améliorer les modèles de stratification des patients constitue un pôle d’attraction de plus en plus important.
Your login attempt was not successful. Please try again.
Setup is fast and easy. Click below to register.
To view the complete webinar, choose from the available formats below, and simply click on the corresponding link. You must have the appropriate player to play the file. For more info on video players, please click here.